Source: Switzerland – Department of Home Affairs
Headline: Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland
Vaccine from Pfizer/BioNTech authorised in the rolling review procedure after close scrutiny of the risks and benefits
Swissmedic has authorised the vaccine from Pfizer/BioNTech. According to the data assessed by the Swiss Agency for Therapeutic Products, the level of protection afforded seven days after the second injection of the vaccine is over 90 percent. This represents the world’s first authorisation in the ordinary procedure.
